You are invited to participate in a global survey on thromboprophylaxis practices for patients with cancer receiving ambulatory systemic therapies. This survey aims to understand current practices, assess guideline adherence and identify gaps in the implementation of these strategies. It will also explore the role of pharmacists in optimising cancer-associated thrombosis (CAT) prevention.
The survey will take approximately 15 minutes to complete. The survey will remain open until Monday, May 26, 2025.
Click here to access the survey
This important initiative has been developed in collaboration with oncology pharmacists and is supported by professional oncology organisations worldwide. Insights gathered will help shape future strategies to enhance evidence-based care for patients at risk of CAT.